OBJECTIVES

The burden of healthcare-associated viral respiratory infections (HAVRIs) among children is significant. While healthcare workers are often the focus for infection prevention strategies, little is known about the impact of sick caregivers and hospital visitors on the incidence of pediatric HAVRIs. The objective of this descriptive study was to determine the proportion of pediatric HAVRIs following contact with a sick caregiver or visitor.

METHODS

A retrospective chart review was performed of all HAVRIs that occurred between December 2017 and July 2019 in a pediatric tertiary care center. A HAVRI was defined as a laboratory-confirmed respiratory viral illness occurring more than 72 hours after admission.

RESULTS

Forty-four HAVRIs occurred in 37 patients during the study, predominantly among patients aged <24 months (n = 32, 72.7%) and with comorbidities (n = 42, 95.5%). For 9 HAVRIs (20.5%), contact with a sick caregiver (n = 8, 18.2%) or visitor (n = 2, 4.5%) in the 7 days before diagnosis was documented. In the 72 hours before HAVRI onset, 18 of the 44 patients (40.9%) were in a single-bed room and 6 of them (33.3%) were under additional precautions. Twelve patients (27.3%) had new or increased oxygen requirements and 4 (9.1%) were transferred to the ICU. There were no associated deaths.

CONCLUSIONS

Contact with a sick caregiver or visitor is a potential risk factor for acquiring a HAVRI. Our study reinforces the importance of engaging family caregivers in infection prevention and control strategies in pediatric care settings.

The burden of health care-associated viral respiratory infections (HAVRIs) among children has been increasingly recognized in the past 10 years.15  Health care workers play a major role in preventing HAVRIs by performing appropriate hand hygiene, wearing personal protective equipment, and not working when symptomatically unwell. However, caregivers and visitors are also potential vectors of viral illnesses. Measures to screen or to limit visitors have proven to be effective and has been the prevailing prevention strategy among pediatric hospitals during the coronavirus disease 2019 (COVID-19) pandemic.69  Yet sick family caregivers may still enter the hospital, given their essential role at their child’s bedside.

The impact of sick caregivers on the incidence of HAVRIs is unclear. However, they remain at the patient’s bedside for prolonged periods of time and are essential providers of care, including feeding, bathing, and dressing. As our pediatric care partners, better understanding of their role in infection transmission dynamics in the healthcare setting is crucial. The objective of our study was to determine the proportion of pediatric HAVRIs associated with contact with a sick caregiver or a visitor, which we hypothesized to be a risk factor for acquiring a viral respiratory infection. We also sought to determine other risk factors for patients to develop a HAVRI and the associated complications.

A retrospective chart review was performed at a 165-bed pediatric tertiary care center with more than 6700 hospital admissions per year. More than half of the inpatient medicine and hematology-oncology units have multibed rooms, while PICU and NICU consist of single-bed rooms. Year-round, clinical staff are instructed to ask symptomatic caregivers not to stay and visitors to defer their visit. For patients under additional precautions, patients are restricted to 2 caregivers. A stricter visitor-screening policy is in place during peak viral respiratory season (typically December to March), with no child under age 14 years being allowed to visit.

All HAVRI episodes are captured by the Infection Control Program’s routine surveillance activity and entered into a safety reporting system for review and follow up by the clinical unit’s leadership team. HAVRIs reported between December 1, 2017 and July 31, 2019 in patients aged <18 years old were included in the study. A HAVRI was defined as a laboratory-confirmed acute respiratory illness, with symptoms that include rhinorrhea or congestion, cough, and fever, with onset after 72 hours of admission.5  Diagnostic testing for respiratory viral infections was performed in all symptomatic inpatients and consisted of a nasopharyngeal swab or deep nasal suction to detect influenza A and B, and respiratory syncytial virus (RSV). If patients were medically complex, immunocompromised, or admitted to an ICU, a multiplex respiratory panel of 16 viruses (influenza A and B, RSV, adenovirus, enterovirus, parainfluenza 1–4, metapneumovirus, coronavirus [OC43, 229E, NL63], bocavirus and rhinovirus) was performed.

The date of diagnosis was defined as the date of symptom onset and was documented in the report as the event date. Information was obtained through clinical notes and through comments on the safety report. As part of the case investigation, infection control professionals systematically review the patient chart to identify information about caregivers and visitors. Clinicians note the health status of a caregiver when they self-report or are noted to have symptoms at the time of admission and when the child experiences a change in clinical status.

Charts were reviewed and crosschecked (M.P. and N.T.), and data were anonymized and entered in REDCap. The study was granted an exemption from the hospital’s research ethics board review as a quality improvement initiative.

Forty-eight episodes of HAVRIs were reported between December 1, 2017 and July 31, 2019, with 12 events occurring in the winter of 2018 to 2019, which corresponded with the most active respiratory viral season in the province compared with other periods in the study, particularly influenza, rhinovirus and RSV.10  Two episodes were excluded as they occurred in patients aged >18 years. One case was excluded as it did not meet HAVRI case definition and 1 was excluded as chart access was restricted.

Forty-four episodes of HAVRIs in 37 patients were included in the analysis. Seven patients had 2 HAVRI episodes during their hospitalization. Most patients (n = 34, 79.5%) were admitted to an inpatient medicine unit. The remainder were admitted to the hematology-oncology unit, PICU, and NICU (6, 2, and 1, respectively). At the time of HAVRI diagnosis, patients had been admitted for a median of 28.5 days (interquartile range, 10–73.5). More than 50% of HAVRIs occurred outside of peak season (Fig 1). Rhinovirus (45.5%) was the virus most commonly identified, followed by RSV (20.5%), and influenza (13.5%).

FIGURE 1

Distribution of HAVRI episodes across the study period. Solid bar: peak season month; dashed bar: non-peak season month.

FIGURE 1

Distribution of HAVRI episodes across the study period. Solid bar: peak season month; dashed bar: non-peak season month.

Close modal

HAVRIs occurred most frequently among patients aged <2 years and with known comorbidities (Table 1). Almost half the cases (n = 21, 47.7%) were in patients followed by the hospital’s complex care program. This program coordinates the care of patients with medical complexity or fragility, including dependence on medical technology (tracheostomy, tube feeding, supplemental oxygen requirement, etc.).

TABLE 1

Demographic and Clinical Characteristics of Patients Who Developed HAVRI

Characteristicn (%)
n = 44
Gender  
 Female 22 (50) 
Agea  
 Less than 24 mo old 32 (72.7) 
 Ex-preterm, born before 37 wk of pregnancy 7 (15.9) 
Comorbidities  
 At least 1 comorbidity 42 (95.5) 
 Cardiac 10 (22.7) 
 Gastrointestinal 22 (50) 
 Hemato-oncologic 4 (9.1) 
 Primary immunodeficiency 2 (4.5) 
 Secondary immunodeficiency 1 (2.3) 
 Neurologic 17 (38.6) 
 Rheumatologic 1 (2.3) 
 Renal 1 (2.3) 
 Respiratory 21 (47.7) 
 Followed by the complex care program 21 (47.7) 
 Surgery in the 7 d before HAVRI episode 2 (4.5) 
Characteristicn (%)
n = 44
Gender  
 Female 22 (50) 
Agea  
 Less than 24 mo old 32 (72.7) 
 Ex-preterm, born before 37 wk of pregnancy 7 (15.9) 
Comorbidities  
 At least 1 comorbidity 42 (95.5) 
 Cardiac 10 (22.7) 
 Gastrointestinal 22 (50) 
 Hemato-oncologic 4 (9.1) 
 Primary immunodeficiency 2 (4.5) 
 Secondary immunodeficiency 1 (2.3) 
 Neurologic 17 (38.6) 
 Rheumatologic 1 (2.3) 
 Renal 1 (2.3) 
 Respiratory 21 (47.7) 
 Followed by the complex care program 21 (47.7) 
 Surgery in the 7 d before HAVRI episode 2 (4.5) 
a

Median = 1 y old (IQR, 1–11).

In the 72 hours before HAVRI diagnosis, 18 patients (40.9%) were in a single-bed room; of these, 6 (33.3%) were under droplet or contact precautions for another suspected (n = 2) or confirmed (n = 4) viral respiratory illness.

Ten HAVRIs (22.7%) were associated with a documented sick contact in the 7 days before diagnosis. For 9 cases (20.5%), it was with a caregiver (n = 8, 18.2%) or visitor (n = 2, 4.5%). Of note, 1 case had sick contacts with both a caregiver and a visitor. Those 9 patients had been admitted for a median of 23 days (interquartile range, 8.5–50) at the time of HAVRI diagnosis. There was no documentation of sick healthcare workers. In only 1 case, a contact with a symptomatic roommate who had been admitted with the same virus was documented in the chart of the HAVRI case. Six patients (13.6%) went home for a day pass at least once in the 7 days before their diagnosis and half of those cases were during peak season.

The most common complications associated with HAVRI episodes were increased duration of additional precautions, suspected bacterial infection with receipt of antibiotics, and increased oxygen requirements (Table 2). There were no associated deaths.

TABLE 2

Complications Developed by Patients Secondary to HAVRI

Complicationn (%)
n = 44
Respiratory support 
 New or increased O2 requirements 12 (27.3) 
 New respiratory support 3 (9.1) 
Other treatments 
 Oseltamivir 6 (13.6) 
 Proven or suspected associated bacterial infection requiring empirical antibiotics 14 (31.8) 
 Proven or suspected associated bacterial infection requiring antibiotics for more than 48 h 9 (20.5) 
Burden on health care 
 Transferred to PICU 4 (9.8a
 Delay in discharge 7 (15.9) 
 More than 7 d under isolation precautions 30 (68.1) 
Complicationn (%)
n = 44
Respiratory support 
 New or increased O2 requirements 12 (27.3) 
 New respiratory support 3 (9.1) 
Other treatments 
 Oseltamivir 6 (13.6) 
 Proven or suspected associated bacterial infection requiring empirical antibiotics 14 (31.8) 
 Proven or suspected associated bacterial infection requiring antibiotics for more than 48 h 9 (20.5) 
Burden on health care 
 Transferred to PICU 4 (9.8a
 Delay in discharge 7 (15.9) 
 More than 7 d under isolation precautions 30 (68.1) 
a

Excluding patients already initially admitted to PICU (2 patients) and NICU (1 patient).

Our study shows that 1 in 5 pediatric HAVRIs were associate with an ill caregiver or visitor and underscore the importance of including family caregivers in quality improvement initiatives focused on HAVRI prevention. As the burden and outcomes in the pediatric population are significant, additional efforts should be allocated to their prevention, including caregiver screening, hand hygiene, masking for source control, and promotion of vaccination against influenza and SARS-CoV-2. As a HAVRI is known to increase the cost of an individual patient’s stay from 1.6 to 2.2 times,3,11  financial resources invested in prevention would arguably be cost-effective.

A similar study found that 30% of HAVRIs were linked to a sick caregiver or visitor.12  Despite the seasonality of some viruses, the authors noted that HAVRIs could be identified year-round. In our study, HAVRIs were distributed evenly between peak and nonpeak season, suggesting that preventive measures should be applied year-round.

The study period ended before the COVID-19 pandemic; at this time, our institution has restricted nonhousehold visitors and siblings and initiated active screening among essential caregivers for COVID-19 symptoms upon hospital entry. Interestingly, we have since noted a much lower number of HAVRIs, with only 10 episodes reported between March 1, 2020 and February 28, 2021. As other factors arguably contributed to this reduction, including mandatory entry-screening for staff and universal masking for source control, this supports visitor policies and entrance screening for infectious symptoms as effective control measures.

More than one-third of HAVRI episodes occurred in patients already in a single-bed room, suggesting that a single-bed room alone is not necessarily protective and supports the implementation of other bedside strategies. Hand hygiene is universally considered an effective preventive measure for healthcare-associated infections.13,14  However, adherence to hand hygiene by caregivers and visitors has been shown to be variable and suboptimal, ranging between 0 and 57%.1521  A recent study conducted in a pediatric hospital and a maternity hospital showed a low hand hygiene rate of 11% among visitors.21  Hospitals should engage family caregivers as partners in infection prevention and control to develop education resources to help protect children from acquiring a viral respiratory infection during the course of their admission. This is highly relevant to the current context, in which the main circulating respiratory virus in most communities, SARS-CoV-2, can be transmitted during the presymptomatic and early symptomatic periods, underlining the importance of distancing, handwashing, and masking for source control if no alternate caregivers are available at the bedside.

In our institution, during the winter season, day passes are restricted to those that are medically necessary, recognizing the risk of exposure to viruses circulating in the community. In our study, 6 patients went on a day pass in the week before their diagnosis of HAVRI and it is possible that their infection might not have been acquired in the hospital. However, there are policies to instruct the family on infection prevention behaviors as well as to screen the family and patient for symptoms and community exposures before leaving and after returning from pass.

Our findings are consistent with other studies that have shown that patients with underlying conditions, especially respiratory fragility, and of a younger age were most likely to become symptomatic due to a hospital-associated infection.5,22  In addition to their baseline fragility, medically complex patients and infants usually require more frequent and closer contacts with healthcare workers and caregivers, which can increase their risk of acquiring HAVRIs in the absence of strict adherence to infection control measures.

Our study has several limitations. As the definition of HAVRI in our center requires a laboratory confirmation of the infection, viruses excluded from our multiplex viral respiratory panel would have been missed, potentially leading to under-diagnosis. On the other hand, a virus identified by molecular methods can reflect a remote infection and not the source of the change in clinical status. It is also possible that we missed HAVRIs in patients who developed symptoms in the 48 to 72 hours following discharge. This could have led to an over-representation of children with medical fragility as they are more likely to remain hospitalized.

Another limitation is that viral testing is not standardized in our institution, with some patients getting tested only for influenza and RSV while others for 13 additional viruses. As a consequence, there is likely an under-estimation of HAVRI’s, particularly those not associated with influenza or RSV. This ascertainment bias would impact HAVRI rates throughout the year and may contribute to the over-representation of medically complex patients observed in our study, in whom additional testing with a multiplex assay was systematically performed. Also, the surveillance definition of HAVRI is not based on virus-specific incubation periods. However, none of the HAVRIs in our study would have been classified as community-acquired based on the time from admission.23  It is possible that we missed HAVRIs that followed 1- or 2-day incubation periods, but we expect this number to be small.

The retrospective design might have led to an underestimation of sick contacts. However, a review of sick contacts is systematically done by infection control professionals at the time of the safety report, and we likely captured most of them. We were unable to establish any causal link between caregivers or visitors and patients’ infection since adults do not receive a test to confirm their respiratory viral infection. Having a comparison group would enable us to assess the odds of developing a HAVRI when a caregiver or visitor had an illness history. Finally, the study was conducted in a single center and the findings might not be generalizable to all settings.

In conclusion, caregivers and visitors may represent a potential source of infection for pediatric patients during hospitalization. As care partners, family caregivers should receive educational resources about strategies to minimize their risks of infection transmission during their child’s hospitalization. Prospective case-control studies are required for better assessment of HAVRI risk factors.

FUNDING: No external funding.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no financial relationships relevant to this article to disclose.

Dr Paquette designed the study and the data collection instrument, collected the data, drafted the initial manuscript, and approved it as submitted; Ms Shephard and Ms Bedard reviewed the study design and the data collection instrument, reviewed the manuscript and approved it as submitted; Dr Thampi designed the study, supervised data collection, and critically reviewed the manuscript and approved it as submitted.

1.
Sidler
JA
,
Haberthür
C
,
Dumoulin
A
,
Hirsch
HH
,
Heininger
U
.
A retrospective analysis of nosocomial viral gastrointestinal and respiratory tract infections [published correction appears in Pediatr Infect Dis J.2013;32(4):e177]
.
Pediatr Infect Dis J
.
2012
;
31
(
12
):
1233
1238
2.
Torres-García
M
,
Pérez Méndez
BB
,
Sánchez Huerta
JL
et al
.
Healthcare-associated pneumonia: don’t forget about respiratory viruses!
Front Pediatr
.
2019
;
7
:
168
3.
Zinna
S
,
Lakshmanan
A
,
Tan
S
et al
.
Outcomes of nosocomial viral respiratory infections in high-risk neonates
.
Pediatrics
.
2016
;
138
(
5
):
e20161675
4.
Poole
CL
,
Camins
BC
,
Prichard
MN
,
Faye-Petersen
O
,
Hutto
C
.
Hospital-acquired viral respiratory infections in neonates hospitalized since birth in a tertiary neonatal intensive care unit
.
J Perinatol
.
2019
;
39
(
5
):
683
689
5.
Vayalumkal
JV
,
Gravel
D
,
Moore
D
,
Matlow
A
;
Canadian Nosocomial Infection Surveillance Program
.
Surveillance for healthcare-acquired febrile respiratory infection in pediatric hospitals participating in the Canadian Nosocomial Infection Surveillance Program
.
Infect Control Hosp Epidemiol
.
2009
;
30
(
7
):
652
658
6.
Forkpa
H
,
Rupp
AH
,
Shulman
ST
et al
.
Association between children’s hospital visitor restrictions and healthcare-associated viral respiratory infections: a quasi-experimental study
.
J Pediatric Infect Dis Soc
.
2020
;
9
(
2
):
240
243
7.
Mermel
LA
,
Jefferson
JA
,
Smit
MA
,
Auld
DB
.
Prevention of hospital-acquired respiratory viral infections: assessment of a multimodal intervention program
.
Infect Control Hosp Epidemiol
.
2019
;
40
(
3
):
362
364
8.
Washam
M
,
Woltmann
J
,
Ankrum
A
,
Connelly
B
.
Association of visitation policy and health care-acquired respiratory viral infections in hospitalized children
.
Am J Infect Control
.
2018
;
46
(
3
):
353
355
9.
Kitano
T
,
Piché-Renaud
P-P
,
Groves
HE
,
Streitenberger
L
,
Freeman
R
,
Science
M
.
Visitor restriction policy on pediatric wards during novel coronavirus (COVID-19) outbreak: a survey study across North America
.
J Pediatric Infect Dis Soc
.
2020
;
9
(
6
):
766
768
10.
PHO
.
Ontario Respiratory Pathogen Bulletin: Surveillance Season (September 1, 2018 - August 31, 2019)
.
Ontario Agency for Health Protection and Promotion
;
2019
11.
Macartney
KK
,
Gorelick
MH
,
Manning
ML
,
Hodinka
RL
,
Bell
LM
.
Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control
.
Pediatrics
.
2000
;
106
(
3
):
520
526
12.
Hei
H
,
Bezpalko
O
,
Smathers
SA
,
Coffin
SE
,
Sammons
JS
.
Development of a novel prevention bundle for pediatric healthcare-associated viral infections
.
Infect Control Hosp Epidemiol
.
2018
;
39
(
9
):
1086
1092
13.
Most
ZM
.
Beyond personal protective equipment: adjunctive methods for control of healthcare-associated respiratory viral infections
.
Curr Opin Infect Dis
.
2020
;
33
(
4
):
312
318
14.
Guidelines WHO Approved by the Guidelines Review Committee
.
WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care
.
Geneva
:
World Health Organization
;
2009
15.
Birnbach
DJ
,
Rosen
LF
,
Fitzpatrick
M
,
Arheart
KL
,
Munoz-Price
LS
.
An evaluation of hand hygiene in an intensive care unit: are visitors a potential vector for pathogens?
J Infect Public Health
.
2015
;
8
(
6
):
570
574
16.
Birnbach
DJ
,
Nevo
I
,
Barnes
S
et al
.
Do hospital visitors wash their hands? Assessing the use of alcohol-based hand sanitizer in a hospital lobby
.
Am J Infect Control
.
2012
;
40
(
4
):
340
343
17.
Kim
D
,
Lee
O
.
Effects of audio-visual stimulation on hand hygiene compliance among family and non-family visitors of pediatric wards: a quasi-experimental pre-post intervention study
.
J Pediatr Nurs
.
2019
;
46
:
e92
e97
18.
Randle
J
,
Firth
J
,
Vaughan
N
.
An observational study of hand hygiene compliance in paediatric wards
.
J Clin Nurs
.
2013
;
22
(
17-18
):
2586
2592
19.
Randle
J
,
Arthur
A
,
Vaughan
N
.
Twenty-four-hour observational study of hospital hand hygiene compliance
.
J Hosp Infect
.
2010
;
76
(
3
):
252
255
20.
Al-Dorzi
HM
,
Matroud
A
,
Al Attas
KA
et al
.
A multifaceted approach to improve hand hygiene practices in the adult intensive care unit of a tertiary-care center
.
J Infect Public Health
.
2014
;
7
(
4
):
360
364
21.
Lee
Z
,
Lo
J
,
Luan
YL
et al
.
Patient, family, and visitor hand hygiene knowledge, attitudes, and practices at pediatric and maternity hospitals: a descriptive study
.
Am J Infect Control
.
2021
;
49
(
8
):
1000
1007
22.
Kobayashi
H
,
Shinjoh
M
,
Sudo
K
et al
.
Nosocomial infection by human bocavirus and human rhinovirus among paediatric patients with respiratory risks
.
J Hosp Infect
.
2019
;
103
(
3
):
341
348
23.
Chow
EJ
,
Mermel
LA
.
Hospital-acquired respiratory viral infections: incidence, morbidity, and mortality in pediatric and adult patients
.
Open Forum Infect Dis
.
2017
;
4
(
1
):
ofx006